These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 33195698)

  • 61. Cardiac Optogenetics: 2018.
    Boyle PM; Karathanos TV; Trayanova NA
    JACC Clin Electrophysiol; 2018 Feb; 4(2):155-167. PubMed ID: 29749932
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [The immediate and long-term efficacy of electrical cardioversion in atrial fibrillation].
    Frabetti L; Carioli E; Antonioli P; Ferrari G; Magnani B
    Cardiologia; 1993 Sep; 38(9):561-7. PubMed ID: 8287385
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Ibutilide in persistent atrial fibrillation refractory to conventional cardioversion methods.
    Naegeli B; Straumann E; Bertel O
    Int J Cardiol; 2005 Mar; 99(2):283-7. PubMed ID: 15749188
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Electrical cardioversion for atrial fibrillation and flutter.
    Mead GE; Flapan AD; Elder AT
    Cochrane Database Syst Rev; 2002; (1):CD002903. PubMed ID: 11869642
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Role of an aggressive rhythm control strategy on sinus rhythm maintenance following intra-operative radiofrequency ablation of atrial fibrillation in patients undergoing surgical correction of valvular disease.
    Sponga S; Leoni L; Buja G; Nalli C; Voisine P; Gerosa G
    J Cardiol; 2012 Oct; 60(4):316-20. PubMed ID: 22898332
    [TBL] [Abstract][Full Text] [Related]  

  • 66. An update on electrical cardioversion of atrial fibrillation.
    Mittal S; Stein KM; Markowitz SM; Iwai S; Guttigoli A; Lerman BB
    Card Electrophysiol Rev; 2003 Sep; 7(3):285-9. PubMed ID: 14739729
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Management of atrial fibrillation in the elderly.
    Aronow WS
    Minerva Med; 2009 Feb; 100(1):3-24. PubMed ID: 19182738
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effectiveness and costs of chemical versus electrical cardioversion of atrial fibrillation.
    de Paola AA; Figueiredo E; Sesso R; Veloso HH; Nascimento LO;
    Int J Cardiol; 2003 Apr; 88(2-3):157-66. PubMed ID: 12714194
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Functional capacity before and after cardioversion of atrial fibrillation: a controlled study.
    Gosselink AT; Crijns HJ; van den Berg MP; van den Broek SA; Hillege H; Landsman ML; Lie KI
    Br Heart J; 1994 Aug; 72(2):161-6. PubMed ID: 7917690
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effects of transcatheter cardioversion on chronic lone atrial fibrillation.
    Kumagai K; Yamanouchi Y; Hiroki T; Arakawa K
    Pacing Clin Electrophysiol; 1991 Nov; 14(11 Pt 1):1571-5. PubMed ID: 1721144
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Atrial fibrillation: always cardioversion? No].
    Di Pasquale G; Biancoli S; Sassone B; Pancaldi LG
    Ital Heart J Suppl; 2002 Jan; 3(1):81-90. PubMed ID: 11899578
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Higher energy synchronized external direct current cardioversion for refractory atrial fibrillation.
    Saliba W; Juratli N; Chung MK; Niebauer MJ; Erdogan O; Trohman R; Wilkoff BL; Augostini R; Mowrey KA; Nadzam GR; Tchou PJ
    J Am Coll Cardiol; 1999 Dec; 34(7):2031-4. PubMed ID: 10588220
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Non-pharmacologic treatment of atrial fibrillation].
    Csanádi Z; Fazekas T; Varró A
    Orv Hetil; 2003 Jun; 144(26):1279-89. PubMed ID: 12894672
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Current management of symptomatic atrial fibrillation.
    Haghi D; Schumacher B
    Am J Cardiovasc Drugs; 2001; 1(2):127-39. PubMed ID: 14728042
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Dofetilide: a review of its use in atrial fibrillation and atrial flutter.
    McClellan KJ; Markham A
    Drugs; 1999 Dec; 58(6):1043-59. PubMed ID: 10651390
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Anticoagulation for cardioversion of atrial fibrillation.
    El Gendi H; Ismail T; Charalampos K; Mayet J
    Minerva Cardioangiol; 2002 Feb; 50(1):43-52. PubMed ID: 11830718
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Should every patient with atrial fibrillation have the rhythm converted to sinus rhythm?
    Mandel WJ
    Clin Cardiol; 1994 Sep; 17(9 Suppl 2):II16-20. PubMed ID: 7882609
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Atrial fibrillation: restoration and maintenance of sinus rhythm and indications for anticoagulation therapy.
    Golzari H; Cebul RD; Bahler RC
    Ann Intern Med; 1996 Aug; 125(4):311-23. PubMed ID: 8678396
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Atrial stunning: basics and clinical considerations.
    Khan IA
    Int J Cardiol; 2003 Dec; 92(2-3):113-28. PubMed ID: 14659842
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Improving outcomes in patients with atrial fibrillation: rationale and design of the Early treatment of Atrial fibrillation for Stroke prevention Trial.
    Kirchhof P; Breithardt G; Camm AJ; Crijns HJ; Kuck KH; Vardas P; Wegscheider K
    Am Heart J; 2013 Sep; 166(3):442-8. PubMed ID: 24016492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.